Clear Street’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,740
Closed -$28.4K 1589
2023
Q1
$28.4K Buy
2,740
+100
+4% +$1.01K ﹤0.01% 323
2022
Q4
$26K Buy
+2,640
New +$26.3K ﹤0.01% 343
2022
Q1
Sell
-8,980
Closed -$90K 575
2021
Q4
$90K Buy
+8,980
New +$90.2K ﹤0.01% 72